Technologies to Watch in 2018, Part 1

ARTICLE SUMMARY:

In Part 1 of this year’s Technologies to Watch compilation, we include, in the cardiovascular space, transcatheter heart valves; the progress of TAVR in expanding into lower-risk groups of patients, and advances in mitral and tricuspid valve development; we examine spinal cord stimulation for chronic pain; how liquid biopsy is helping to drive precision medicine; the forward momentum of minimally invasive glaucoma surgery; and finally, how AI is reaching into medtech.

By Mary Thompson and the MedTech Strategist editorial team

Each year, the MTS editorial team selects several areas within medtech that warrant special attention for our “Technologies to Watch” compilation article. These could be technologies that are driving growth and innovation in particular markets, those with the potential to disrupt an existing space, or even those that have stirred controversy or faced challenges in recent months.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.


Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite

Questions?

We're here to help! Please contact us at: